<SEC-DOCUMENT>0000895345-22-000827-index.html : 20221219
<SEC-HEADER>0000895345-22-000827.hdr.sgml : 20221219
<ACCEPTANCE-DATETIME>20221219161011
ACCESSION NUMBER:		0000895345-22-000827
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20221219
DATE AS OF CHANGE:		20221219

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akebia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001517022
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				208756903
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88058
		FILM NUMBER:		221471171

	BUSINESS ADDRESS:	
		STREET 1:		245 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-871-2098

	MAIL ADDRESS:	
		STREET 1:		245 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Satter Muneer A
		CENTRAL INDEX KEY:			0001315797

	FILING VALUES:
		FORM TYPE:		SC 13G

	MAIL ADDRESS:	
		STREET 1:		C/O SATTER INVESTMENT MANAGEMENT, LLC
		STREET 2:		676 NORTH MICHIGAN AVENUE, SUITE 4000
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60611
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>ff-1614699_13g-satter.htm
<TEXT>
Document 1 - file: ff-1614699_13g-satter.htm

</DOCUMENT>
</SEC-DOCUMENT>